Scientia Advisors Management Consultant and Managing Partner, Harry Glorikian, will be a Panelist at MIT Enterprise Forum of Cambridge

Cambridge, MA, September 26, 2007 --(PR.com)-- The Start-Up Clinic consists of an audience of 40-50 people who listen (and react) to two presentations by early stage companies and comments from 3-4 panelists.

Many of the presenters have a business plan but have not yet raised money. Some of the companies may have already started making sales. Every company wants to benefit from an outside, experienced view of the business plan and a dry run at an investor presentation.

Panelists review the presenters' business plans which are provided in advance to the panel. Panelists are experienced business people but are not expected to be experts on any of the businesses or technologies described by the entrepreneur or in the plans.

Presenters: David Luccino (Stericoat Corporation), Ching-Hua Tseng ( Aretais).

Panelists: Harry Glorikian – Managing Partner (Scientia Advisors), Richard Lim (MVM Life Science Partners LLP), Jeffrey Quillen – Partner (Foley Hoag LLP), Elaine I. Allen – Associate Professor of Statistics and Entrepreneurship (Babson).

http://www.mitforumcambridge.org/events/clinics.html

Harry Glorikian’s experience allows him to cover a broad range of areas within life sciences. His direct experience in sales, marketing, business development, and intellectual property combined with his technical and market knowledge provides unique and insightful perspectives. Harry has 15 years of experience in the life sciences developing and executing key strategic acquisitions and licensing arrangements targeting revenue growth channels. Harry currently leads Scientia, including the management of consulting teams, new business development, and intellectual capital development. His client engagements have involved comprehensive go-to-market plans in the areas of diagnostics, genomic, proteomics, cell biology, cellular therapy and consumables & services groups. His clients include both emerging innovators and global market leaders.

###